Clinical Trial Update: Esketamine on Postpartum Depression in Cesarean Section Women [NA]

View source ↗

Summary

A completed clinical trial evaluating esketamine for postpartum depression in women following cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Ailin Luo | Conditions: Esketamine, Postpartum Depression | NA | Status: COMPLETED